GLP-1 Hub: Support, Community, and Weight Loss

Send us Fan Mail
Jamie Selzler weighed 652 pounds. Four years later, he's lost 370 on a GLP-1 without bariatric surgery. And the lesson he wants you to take has nothing to do with the scale.

Ana Reisdorf, MS, RD sits down with Jamie Selzler, who has lost 370 pounds over four years on a GLP-1 with no surgery. They cover the airplane conversation with an endocrinologist that first opened the door, the three turning points in three weeks that finally made him act, the four mindset rules he developed along the way, how he rebuilt movement into his life from a starting point of needing a walker, and the message about self-worth he wants every person at the very beginning of their journey to hear.

IN THIS EPISODE
- The decades of failed dieting that came before — Slim-Fast, Atkins, Optifast, and a 100-pound regain
- The three turning points in three weeks that pushed him to finally act
- The four mindset rules that made this attempt different (and why motivation isn't one of them)
- How he started movement at 550 pounds and now walks 12,000+ steps a day
- The self-worth message he wants every person in the very beginning of their GLP-1 journey to hear

ABOUT THE GUEST
Jamie Selzler is a certified personal trainer with the National Academy of Sports Medicine who has lost 370 pounds over four years on a GLP-1, going from 652 pounds to under 285 without bariatric surgery. Featured in The New York Times and followed by more than 100,000 people on social media, Jamie now works with NASM to help reshape how the fitness industry treats people on GLP-1 medications. His mission is to make movement accessible — physically and emotionally — for anyone who has struggled with obesity.

CONNECT WITH JAMIE
Website: https://myonechange.com
Instagram: https://www.instagram.com/jselzler/
Tiktok: https://www.tiktok.com/@jamselz

SPONSOR
Tyde Wellness — sustainable weight loss with support, for women.
https://tydewellness.com/GLP1Hub — use code GLP1HUB50 for $50 off your first month

CHAPTERS
00:00  You can't hate yourself thin
01:37  From 652 pounds and counting
03:26  A history of dieting and broken promises
07:45  The airplane conversation that opened the door
09:07  Three turning points in three weeks
12:40  The four mindset rules
24:43  Starting movement at 550 pounds
29:48  Becoming a certified personal trainer
30:25  Changing how the fitness industry sees GLP-1s
32:36  The one message Jamie wants you to hear

MORE FROM GLP-1 HUB
📬 Get The Steady State, Ana's weekly newsletter with GLP-1 guidance from a dietitian who's on one: http://join.glp-1hub.com

🎙 Subscribe wherever you listen to podcasts, and if this episode helped, leave a quick review on Apple Podcasts or Spotify - it's the single best way to help more people find the show.

🌐 Shop GLP-1 essentials, meal plans, and recipes: https://shop.glp-1hub.com
📷 Follow on Instagram: @glp1hub
📺 Watch on YouTube: https://www.youtube.com/@GLP-1hub
*Some of the links shared are affiliate links. When you make a purchase, I will receive a small commission at no cost to you. Thank you for supporting the show.
*The content of this show is for informational purposes only and does not constitute medical advice. The goal of this show is to provide various points of view about GLP-1 Medications. The personal and professional opinion of the guests and their content does not necessarily reflect the opinion of Ana Reisdorf or GLP-1 Hub.

Send us Fan Mail
Higher dose isn't better. You're supposed to eat. And no, you don't have to be on Ozempic for life. A nurse practitioner who lost 90 pounds breaks down GLP-1 myths.

Ana Reisdorf, MS, RD sits down with Christine Grant, NP, a nurse practitioner at Tyde Wellness and a GLP-1 user who has lost 90 pounds over the last two years. They work through the five myths Christine hears most often in clinic — the "easy way out" framing, the idea you shouldn't be hungry, the belief that higher doses work better, the safety panic, and the "on it for life" assumption — and what the reality actually looks like.

IN THIS EPISODE
- Why undereating on Ozempic, Wegovy, or Zepbound backfires — fatigue, hair loss, and muscle loss
- The 0.5–2 lb per week sweet spot and why higher doses don't mean faster results
- Microdosing for maintenance — what it looks like and who it works for
- The cardiovascular case for staying on a GLP-1 long term
- How to tell when your dose is actually too high (hint: it's not "I'm hungry sometimes")

ABOUT THE GUEST
Christine Grant is an Adult-Gerontology Acute Care Nurse Practitioner with clinical expertise in urgent care and telemedicine, dedicated to evidence-based, patient-centered care. She has a strong interest in wellness and innovative therapies, including peptide therapy, as tools to support energy, recovery, and overall well-being. As a mother of three boys, she understands the demands of balancing health, family, and career. Her personal experience with GLP-1s has strengthened her passion for helping others feel their best and live healthier lives.

CONNECT WITH CHRISTINE
Tyde Wellness: https://tydewellness.com

SPONSOR
Tyde Wellness — sustainable weight loss with support, for women.
https://tydewellness.com/GLP1Hub — use code GLP1HUB50 for $50 off your first month
Timeline - http://timeline.com/GLP1HUB for 20% off your order
Folly — Hair support gummies for GLP-1 users. A 300-person study showed less shedding and fuller hair after 4 weeks. https://follynutrition.com/glp1hub — code GLP1HUB for 20% off

CHAPTERS
00:00  Why I'll be on a GLP-1 forever
01:43  Meet Christine Grant, NP
02:25  Christine's 90-pound GLP-1 journey
04:30  Myth: GLP-1s are the easy way out
07:30  Myth: You don't eat on a GLP-1
15:25  Myth: Higher dose equals better results
20:00  Why weight loss isn't linear
21:30  Myth: GLP-1s are dangerous
23:58  Myth: You're on it for life
30:05  Final advice and where to find Christine

MORE FROM GLP-1 HUB
📬 Get The Steady State, Ana's weekly newsletter with GLP-1 guidance from a dietitian who's on one: http://join.glp-1hub.com

🎙 Subscribe wherever you listen to podcasts, and if this episode helped, leave a quick review on Apple Podcasts or Spotify - it's the single best way to help more people find the show.

🌐 Shop GLP-1 essentials, meal plans, and recipes: https://shop.glp-1hub.com
📷 Follow on Instagram: @glp1hub
📺 Watch on YouTube: https://www.youtube.com/@GLP-1hub
*Some of the links shared are affiliate links. When you make a purchase, I will receive a small commission at no cost to you. Thank you for supporting the show.
*The content of this show is for informational purposes only and does not constitute medical advice. The goal of this show is to provide various points of view about GLP-1 Medications. The personal and professional opinion of the guests and their content does not necessarily reflect the opinion of Ana Reisdorf or GLP-1 Hub.

Send us Fan Mail
Most doctors say GLP-1s are for life. After 12+ years of prescribing Ozempic, Wegovy, and Zepbound, this obesity medicine physician disagrees.

Ana Reisdorf, MS, RD sits down with Dr. William Summers, an obesity medicine physician double board-certified in OB/GYN, who has been prescribing GLP-1s for over a decade and runs clinical trials on the next generation of these medications. They cover his actual tapering protocol, why real-world side effect rates run far below what the media reports, the one rare complication every patient needs to spot early, and why he believes we're only at the very beginning of what obesity medicine can do.

IN THIS EPISODE
- The 9-month tapering protocol for coming off Ozempic, Wegovy, or Zepbound
- Why media-reported GLP-1 side effect rates don't match what physicians see in clinic
- Pancreatitis on GLP-1 medications — the early warning signs every patient should know
- Why some people don't respond to Ozempic or Wegovy (cortisol, leptin, and genetics)
- What's coming next: triple receptor agonists, Foundayo, and the future of obesity medicine

ABOUT THE GUEST
Dr. William Summers is a practicing physician in Birmingham, AL, board certified in OB/GYN and Obesity Medicine.

CONNECT WITH DR. SUMMERS
Practice: The Weight Clinic - http://summersweightclinic.com/
Video series: Weight Management — A Class With ACT -  https://www.youtube.com/@theweightclinic-drsummers

SPONSOR
Tyde Wellness — sustainable weight loss with support, for women.
https://tydewellness.com/GLP1Hub — use code GLP1HUB50 for $50 off your first month

CHAPTERS
00:00  The penicillin of weight loss
01:33  Meet Dr. William Summers
03:48  Why obesity is a disease, not a behavior
06:51  The tapering protocol most doctors don't follow
12:51  What the media gets wrong about side effects
15:55  Pancreatitis: the one to watch for
17:56  Gut impaction, gastroparesis, and constipation
20:43  When GLP-1s don't work and why
25:54  What's coming next: triple agonists and oral pills
31:08  Where to find Dr. Summers

MORE FROM GLP-1 HUB
📬 Get The Steady State, Ana's weekly newsletter with GLP-1 guidance from a dietitian who's on one: http://join.glp-1hub.com

🎙 Subscribe wherever you listen to podcasts, and if this episode helped, leave a quick review on Apple Podcasts or Spotify - it's the single best way to help more people find the show.

🌐 Shop GLP-1 essentials, meal plans, and recipes: https://shop.glp-1hub.com
📷 Follow on Instagram: @glp1hub
📺 Watch on YouTube: https://www.youtube.com/@GLP-1hub
*Some of the links shared are affiliate links. When you make a purchase, I will receive a small commission at no cost to you. Thank you for supporting the show.
*The content of this show is for informational purposes only and does not constitute medical advice. The goal of this show is to provide various points of view about GLP-1 Medications. The personal and professional opinion of the guests and their content does not necessarily reflect the opinion of Ana Reisdorf or GLP-1 Hub.

Send us Fan Mail
14 million seniors may qualify for $50/month Wegovy and Zepbound starting July 1, 2026. Here's exactly how the Medicare GLP-1 Bridge Program works and why the BMI threshold is lower than most people think.

Ana Reisdorf, MS, RD sits down with Joe Zucchi, PA-C, a physician associate and obesity medicine specialist on the board of the New England Obesity Society, to break down the new Medicare GLP-1 Bridge Program launching July 1, 2026. They cover who qualifies, which medications are included, the prior authorization process, what happens after the program expires in 2027, and the senior-specific nutrition risks to watch out for.

IN THIS EPISODE
- The three eligibility categories — including the BMI 27+ pre-diabetes pathway that may qualify millions
- Which medications are covered: Wegovy injections, Wegovy pill, Zepbound QuickPen, and Foundayo
- How to work with your provider on the prior authorization and what documentation actually matters
- What happens after December 31, 2027 — and how the Balance Model is different
- Senior-specific risks: muscle loss, sarcopenia, and how to avoid Medicare GLP-1 scams

ABOUT THE GUEST
Joseph Zucchi, PA-C is the Clinical Supervisor and Physician Associate at Transition Medical Weight Loss in Salem, New Hampshire, where he leads a multidisciplinary obesity medicine program. Under his clinical leadership, the practice has helped patients lose more than 50,000 pounds and has been named Best Weight Loss Center in New Hampshire for three consecutive years. Joe is a board member of the New England Obesity Society and has been featured in The Wall Street Journal, The New York Times, Bloomberg, Healthline, and the Boston Globe. Through his clinical work, teaching, writing, and advocacy, he is committed to advancing evidence-based obesity care and improving long-term health outcomes.

CONNECT WITH JOE
Practice: Transition Medical Weight Loss (Salem, NH) — https://TransitionSalem.com
LinkedIn: https://www.linkedin.com/in/josephzucchi/

SPONSORS
Timeline - http://timeline.com/GLP1HUB for 20% off your order
Folly — Hair support gummies for GLP-1 users. A 300-person study showed less shedding and fuller hair after 4 weeks. https://follynutrition.com/glp1hub — code GLP1HUB for 20% off

RESOURCES
Medicare GLP-1 Bridge Program info: https://www.cms.gov/medicare/coverage/prescription-drug-coverage/medicare-glp-1-bridge

CHAPTERS
00:00  The BMI 27 surprise
01:25  Meet Joe Zucchi, PA-C
02:51  What the Medicare Bridge Program is
06:14  Who qualifies: the three eligibility categories
09:07  The prior authorization process
14:32  Which medications are covered
19:50  What if you're denied
21:55  What happens after December 2027
25:18  Is this just a political promise
28:35  Senior concerns and scam warnings

MORE FROM GLP-1 HUB
📬 Get The Steady State, Ana's weekly newsletter with GLP-1 guidance from a dietitian who's on one: http://join.glp-1hub.com

🎙 Subscribe wherever you listen to podcasts, and if this episode helped, leave a quick review on Apple Podcasts or Spotify - it's the single best way to help more people find the show.

🌐 Shop GLP-1 essentials, meal plans, and recipes: https://shop.glp-1hub.com
📷 Follow on Instagram: @glp1hub
📺 Watch on YouTube: https://www.youtube.com/@GLP-1hub
*Some of the links shared are affiliate links. When you make a purchase, I will receive a small commission at no cost to you. Thank you for supporting the show.
*The content of this show is for informational purposes only and does not constitute medical advice. The goal of this show is to provide various points of view about GLP-1 Medications. The personal and professional opinion of the guests and their content does not necessarily reflect the opinion of Ana Reisdorf or GLP-1 Hub.

Send us Fan Mail
Even elite athletes are on Ozempic - and how they fuel, train, and time their dose looks nothing like the standard GLP-1 advice.

Ana Reisdorf, MS, RD sits down with Umo Callins, RDN, a board-certified sports dietitian and fitness coach with 15+ years working with athletes from recreational to elite. They cover what actually changes when active people go on Ozempic, Wegovy, Zepbound, or Mounjaro — fueling around training, dose timing in the off-season, strength training non-negotiables, creatine, HMB, and protecting muscle mass when your appetite collapses.

IN THIS EPISODE
- What Serena Williams' GLP-1 reveal changes about who these medications are for
- How to fuel before, during, and after running and endurance training on Ozempic or Wegovy
- Why competitive athletes should consider GLP-1s in the off-season, not during competition
- The truth about electrolytes — and why "everyone on a GLP-1 needs them" doesn't hold up
- Creatine and HMB for protecting muscle mass while losing weight on GLP-1 medications

ABOUT THE GUEST
Umo Callins is a board-certified sports dietitian and fitness coach with over 15 years of experience working with athletes, teams, and active individuals. She is the co-owner of 180Physique Athletics, a sports performance facility, and the founder and CEO of Well Rooted Health and Nutrition, a group practice offering individualized and corporate nutrition services. She specializes in bridging the gap between performance nutrition and everyday wellness, and is a media dietitian and brand spokesperson featured on TV, radio, and in digital media. As a mom of three, she brings a grounded, real-world perspective to how nutrition fits into busy, active lives.

CONNECT WITH UMO
Website: https://wellrootedhn.com
Instagram: @sassysportsdietitian

MORE FROM GLP-1 HUB

📬 Get The Steady State, Ana's weekly newsletter with GLP-1 guidance from a dietitian who's on one: http://join.glp-1hub.com

🎙 Subscribe wherever you listen to podcasts, and if this episode helped, leave a quick review on Apple Podcasts or Spotify - it's the single best way to help more people find the show.

🌐 Shop GLP-1 essentials, meal plans, and recipes: https://shop.glp-1hub.com
📷 Follow on Instagram: @glp1hub
📺 Watch on YouTube: https://www.youtube.com/@GLP-1hub
*Some of the links shared are affiliate links. When you make a purchase, I will receive a small commission at no cost to you. Thank you for supporting the show.
*The content of this show is for informational purposes only and does not constitute medical advice. The goal of this show is to provide various points of view about GLP-1 Medications. The personal and professional opinion of the guests and their content does not necessarily reflect the opinion of Ana Reisdorf or GLP-1 Hub.